Compare BBUC & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBUC | MMED |
|---|---|---|
| Founded | 2022 | 1983 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.7B |
| IPO Year | 2015 | 2025 |
| Metric | BBUC | MMED |
|---|---|---|
| Price | $28.02 | $23.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $41.00 | $22.56 |
| AVG Volume (30 Days) | 272.1K | ★ 1.7M |
| Earning Date | 05-08-2026 | 06-03-2026 |
| Dividend Yield | ★ 0.75% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,102,000,000.00 |
| Revenue This Year | N/A | $15.99 |
| Revenue Next Year | N/A | $10.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $26.93 | $10.65 |
| 52 Week High | $38.25 | $24.43 |
| Indicator | BBUC | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 35.01 | 76.98 |
| Support Level | N/A | $10.68 |
| Resistance Level | $32.12 | N/A |
| Average True Range (ATR) | 0.68 | 1.12 |
| MACD | -0.07 | 0.29 |
| Stochastic Oscillator | 11.70 | 91.13 |
Brookfield Business Corp is the operator of vital industrial and business services operations. The company focuses on acquiring market businesses for value, execute its operational improvement plans to increase cash flows and recycle capital to compound long-term growth. Geographically, it derives maximum revenue from the United States, and the rest from Europe, Brazil, Australia, Canada, and others. It operates in four segments within particular sectors namely: business services, infrastructure services, industrials, and corporate. The company derives maximum revenue from Industrials segment engaged in energy storage operations, engineered components manufacturing operations, water and wastewater operations, electric heat tracing systems manufacturer, and other industrials operations.
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.